Prostaglandin Endoperoxides, Synthetic
"Prostaglandin Endoperoxides, Synthetic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Synthetic compounds that are analogs of the naturally occurring prostaglandin endoperoxides and that mimic their pharmacologic and physiologic activities. They are usually more stable than the naturally occurring compounds.
Descriptor ID |
D011450
|
MeSH Number(s) |
D10.251.355.255.550.775.250 D23.469.050.175.725.775.250 D23.469.700.630
|
Concept/Terms |
Prostaglandin Endoperoxides, Synthetic- Prostaglandin Endoperoxides, Synthetic
- Synthetic Prostaglandin Endoperoxides
- Endoperoxides, Synthetic Prostaglandin
- Prostaglandin Endoperoxide Analogues
- Analogues, Prostaglandin Endoperoxide
- Endoperoxide Analogues, Prostaglandin
- Prostaglandin Endoperoxide Analogs
|
Below are MeSH descriptors whose meaning is more general than "Prostaglandin Endoperoxides, Synthetic".
Below are MeSH descriptors whose meaning is more specific than "Prostaglandin Endoperoxides, Synthetic".
This graph shows the total number of publications written about "Prostaglandin Endoperoxides, Synthetic" by people in this website by year, and whether "Prostaglandin Endoperoxides, Synthetic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prostaglandin Endoperoxides, Synthetic" by people in Profiles.
-
Stimulation of rat mesangial cell thromboxane A2 receptors inhibits particulate but not soluble guanylyl cyclase. Am J Physiol. 1996 Jan; 270(1 Pt 2):F31-8.
-
Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. J Pharmacol Exp Ther. 1994 Sep; 270(3):1192-6.
-
Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors. Biochim Biophys Acta. 1994 Mar 10; 1221(1):83-8.
-
Testosterone treatment enhances thromboxane A2 mimetic induced coronary artery vasoconstriction in guinea pigs. Eur J Clin Invest. 1994 Feb; 24 Suppl 1:50-2.
-
Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells. Am J Physiol. 1993 Dec; 265(6 Pt 1):E928-34.
-
Angiotensin II-aldosterone interactions on protein synthesis in vascular smooth muscle cells. Am J Physiol. 1993 Jun; 264(6 Pt 1):C1525-31.
-
Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with pregnancy induced hypertension. Thromb Res. 1993 May 01; 70(3):205-10.
-
Thromboxane A2/prostaglandin H2 receptors in streptozotocin-induced diabetes: effects of insulin therapy in the rat. Prostaglandins. 1993 May; 45(5):427-38.
-
7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors. J Pharmacol Exp Ther. 1992 Aug; 262(2):632-7.
-
Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors. J Pharmacol Exp Ther. 1992 Jul; 262(1):238-45.